A senior bioethicist and director of the Laboratory of Infectious Diseases at the National Institutes of Health — who said he’s willing to risk his medical license — will argue against vaccine mandates during a Dec. 1 livestreamed roundtable.
A senior bioethicist who heads a research team at the National Institute of Allergy and Infectious Diseases (NIAID) is taking the lead at the National Institutes of Health (NIH) in the debate over the ethics of COVID vaccine mandates.
Dr. Matthew Memoli, director of the Laboratory of Infectious Diseases at NIH, will argue against vaccine mandates during a Dec. 1 livestreamed roundtable session, which will be open to the public.
“There’s a lot of debate within the NIH about whether [a vaccine mandate] is appropriate,” David Wendler, a senior NIH bioethicist in charge of planning the session, told the WSJ. “It’s an important, hot topic.”
Memoli opposes mandates for the COVID vaccines authorized for emergency use in the U.S., and has chosen not to be vaccinated.
DTP Vaccine Severely Damages Four-Month-Old Infant For Life
When Matthew got his DTP shot he cried out in pain. Muriel’s heart sank while sharing his pain with him, not even knowing at the time that this would be the last time she would ever see her perfect, happy, healthy little boy again. Within the next few hours he became irritable and cranky. Later in the day, he became feverish and he continued to be very finicky and fussy throughout the day and into the night. By the next day Matthew’s crying was non-stop and hard to bear. Muriel noticed he also looked lethargic and he would stare off into space periodically.
Soon after, she laid him down in his playpen and as he was kicking his feet at the bright colored ball that was hanging over him, he suddenly stopped, turned to his side, his face expressionless and stared blankly. Muriel’s first thought was that he was dead so she leapt off of the couch and rushed to his care but he suddenly snapped out of it. She phoned the pediatrician immediately and after explaining his new behaviors after the DTP shot, the doctor reassured her that he would be just fine – she was just being an over-reactive mother and she had nothing to worry about. With everything inside of her she wanted to believe this doctor but she knew in her heart that Matthew was having an adverse reaction to the DTP vaccine.
Over the next few weeks Matthew continued to worsen. He had more starring spells, flu- like symptoms, a runny nose, fevers and irritability. He seemed to be himself one minute and then tired and lethargic the next. Muriel began to call the pediatrician’s office daily only to be informed that he would be just fine and her anxiety was unfounded. When she mentioned that she thought that the DTP shot had something to do with his declining behaviors the doctor shut her down quickly and assured her that it could not be the case. The doctor mentioned he was probably cutting teeth or had the flu. Matthew was not cutting his teeth and he was not “just fine.” She knew something was wrong and as her worries intensified so did the phone calls to the pediatric office.
After three more frantic phone calls in a twenty-four hour period the doctor finally agreed to see him in her office. As she carried her sick little baby into the pediatric office the doctor took one look at Matthew and confirmed Muriel’s worst nightmare. The doctor immediately began to examine Matthew’s listless head and body and noticed that the fontanel (the soft spot on his head) was full. The doctor immediately advised Muriel to take Matthew to be hospitalized for testing.
After a 25 minute drive to the hospital the staff immediately began running tests on Matthew. At 4 months old he was being poked and prodded while Muriel stood helpless, scared and in shock. Doctors, nurses and other staff members were drawing blood, inserting IV’s and performing a spinal tap. As he lay in the hospital bed Muriel laid next to him. She held his tiny hand, trying to ignore all of the tubes and hospital equipment. Over the next 48 hours Matthew became more seriously ill. His fontanel grew even fuller, Spinal Meningitis was ruled out and he began to have Grand Mal seizures.
Time to Dispel Myths and Lies About Pertussis and Pertussis Vaccines
Pertussis bacteria, CDC
What’s old is new again. And it is time to dispel the myths and lies being told about pertussis and pertussis vaccines.
FACT: Both the reactive whole cell DPT vaccine licensed 1949 and the less toxic acellular DTaP vaccine licensed in 1996 do not prevent infection or transmission, and only provide two to five years of temporary immunity at best;
FACT : Millions of vaccinated children and adults are silently infected with pertussis in the U.S. every year and show few or no symptoms but spread whooping cough to vaccinated and unvaccinated children – without doctors identifying or reporting cases to the government;
FACT : In response to mass pertussis vaccination campaigns beginning in the 1950s, the B. pertussis microbe evolved to evade both whole cell and acellular pertussis vaccines, creating new strains producing more toxin to suppress immune function and cause more serious disease.
No Herd Immunity: Vaccines Do Not Block Infection, Carriage or Transmission
When there are a lot of people with silent asymptomatic pertussis infections, it is impossible to know who is a carrier and who is not, which means that reported cases of pertussis are just the tip of a very big iceberg. It also means that articles blaming whooping cough cases on unvaccinated or partially vaccinated children are nothing more than wishful thinking and scapegoating. 46
Bottom Line: Both natural and vaccine acquired immunity is temporary 47 and while vaccination may prevent clinical symptoms, it does not block infection, carriage or transmission. If vaccinated people can get silently infected and transmit infection without showing any symptoms – even after getting four to six pertussis shots – then pertussis vaccine acquired “herd immunity” is an illusion and always has been.
So the big question is: Why has more than a half-century of pertussis vaccination failed to produce true herd immunity like public health officials insist it theoretically can if only more and more pertussis shots are given to more people more of the time? 48 49
Extremely Reactive DPT and Less Reactive DTaP both Have Low Efficacy
The inconvenient set of scientific facts they have to work with are these:
FACT: The efficacy of whole cell pertussis vaccine in the DPT shot was measured to be between 30 and 85 percent, depending upon the type of DPT and vaccine manufacturer, 56 57 58 59 60 and protection lasted two to five years. 61
FACT: After a low of about 1,000 cases of pertussis were reported in the U.S in 1976, 62 it was obvious all through the1980s and 90’s that whole cell pertussis vaccine in DPT shots was not preventing infection or transmission.63 64 65 66 67 Pertussis cases increased in highly vaccinated populations in cycles of three to five years – just like before DPT vaccine was widely used in the 1950s. 68 69 70 71 72
FACT: The whole cell DPT vaccine used until the late 1990’s in the U.S. was an extremely reactive vaccine. DPT vaccine reactions like fever, pain, and irritability were experienced by between 50 and 85 percent of children and seizures and collapse/shock reactions followed one in 875 DPT shots. 73 74 Brain inflammation was reported following 1 in 110,000 DPT shots with permanent brain damage after 1 in 310,000 DPT shots. 75 76 Finally, in 1996, the marginally effective and extremely reactive whole cell DPT vaccine was replaced with a far less reactive but marginally effective acellular DTaP vaccine. 77 Similar to whole cell pertussis vaccines, acellular pertussis vaccine efficacy in clinical trials was measured to be between 40 and 89 percent, depending upon the DTaP vaccine manufacturer. 78 79 80
FACT: Acellular pertussis vaccines do not prevent infection, 81 82 just like whole cell pertussis vaccines do not prevent infection. In the 21st century, pertussis outbreaks and cyclical increases have continued,83 84 85 – even after a pertussis booster shot was added to the schedule for all adolescents and adults in 2006. 86 87 By 2010, the Tdap pertussis booster shot was found to be only about 66 percent effective in providing temporary immunity for teenagers and adults. 88